GL1X · GenesisL1 explorer

Research workbench

The crystal structure of human DYRK2 in complex with curcumin

Analyse The crystal structure of human DYRK2 in complex with curcumin in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5ZTN
Type
protein
Length
794 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Dual specificity tyrosine-phosphorylation-regulated kinase 2
EC
2.7.12.1
UniProt
Q92630
Ligands
CUR
Pockets
9 · best druggability 0.76

Structure

x-ray diffraction · 1 distinct chain · 35% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BDual specificity tyrosine-phosphorylation-regulated kinase 2 (EC 2.7.12.1)protein39735% helix, 17% strandQ92630

Ligands and binding sites

  • CUR · (1Z,4Z,6E)-5-hydroxy-1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,4,6-trien-3-one · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

9 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18720.760.8090CUR
28390.760.8082CUR
32220.560.7930empty
41880.500.7730empty
5930.450.8021empty

Interfaces

1 interface between chains.

  • A–B · 1010 Ų buried · 18 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 modified (phosphorylation).

Compared structures

  • 5ZTN · The crystal structure of human DYRK2 in complex with Curcumin · the same entry in another collection · chain A against A, TM-score 1.00
  • Q92630 · AlphaFold monomer V2.0 prediction for dual specificity tyrosine… · a predicted model of the same protein · chain A against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.